Tue.Jul 16, 2024

article thumbnail

Heparin provides a cheap antidote for cobra bites

Drug Discovery World

Scientists at the University of Sydney and Liverpool School of Tropical Medicine have revealed that a commonly used blood thinner, heparin, can be repurposed as an inexpensive antidote for cobra venom. Cobras kill thousands of people a year worldwide and many more are seriously maimed by necrosis caused by the venom, which can lead to amputation. The World Health Organization has announced a goal of reducing the global burden of snakebite in half by 2030.

Science 130
article thumbnail

Investigating potential mechanisms of vitamin D against thyroid cancer via network pharmacology and experimental validation

Chemical Biology and Drug Design

This study provides preliminary elucidation of multiple pharmacological targets, biological processes and signaling pathways of VD against TC. These findings offer valuable insights for future therapeutic strategies targeting TC. Abstract Thyroid cancer (TC) is one of the most common endocrine malignancies worldwide. Increasing evidence suggests that vitamin D (VD) has potential benefits in the treatment of TC.

Treatment 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why is Gen-Z choosing to work in pharma?

Drug Discovery World

Younger workers in the UK are increasingly choosing careers in pharmaceuticals over other industries like technology or finance due to perceptions of better work life balance and social purpose in the sector. This is according to a new report ‘Young people’s perceptions of careers in the pharmaceutical industry’, commissioned by the Association of the British Pharmaceutical Industry (ABPI).

article thumbnail

Therapeutic potential and recent progression of BTK inhibitors against rheumatoid arthritis

Chemical Biology and Drug Design

Several Bruton's tyrosine kinase (BTK) inhibitors have been shown in studies to be effective in the inhibition of biological activity analysis and in animal models. This review focuses on the BTK inhibition mechanism and its possible impact on immune-mediated disease, as well as the types being investigated for RA, preclinical and clinical investigations and future research opportunities.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Adding value to regulatory intelligence with generative AI

Drug Discovery World

There is limitless scope for generative AI to transform regulatory processes. But where to start? ArisGlobal’s Agnes Cwienczek and Renato Rjavec describe use cases where AI is already delivering tangible everyday benefits. As life sciences companies’ investments in regulatory data capture, enrichment and exchange continue to rise in line with agency mandates, the potential scope for artificial intelligence (AI) and generative AI seems limitless in its promise to transform labour-intensive proces

Science 130
article thumbnail

Scientists find that small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa

Science Daily: Pharmacology News

For the first time, scientists have found that sleep can be detected by patterns of neuronal activity just milliseconds long, 1000 times shorter than a second, revealing a new way to study and understand the basic brain wave patterns that govern consciousness.

More Trending

article thumbnail

Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex

BioPharma Drive: Drug Pricing

The well-funded startup says drugs AbbVie abandoned last year could form a combination regimen with “superior efficacy” to Vertex’s market-leading medicines.

Drugs 112
article thumbnail

'Staying Regular' Is Good for Good Health

Drugs.com

TUESDAY, July 16, 2024 -- Being regular is good for you, a new study shows.Predictable bowel movements could be tied to your long-term health, allowing your body to absorb essential nutrients without producing harmful organ-damaging toxins.

98
article thumbnail

Navigating Patent Opposition in Drug Patenting: A Comprehensive Guide

Drug Patent Watch

Introduction Patent oppositions are a crucial tool in the pharmaceutical industry, allowing civil society to challenge the validity of patents […] Source

article thumbnail

Parents, Take Note: Survey Shows Teens Need More Support Than They Get

Drugs.com

TUESDAY, July 16, 2024 -- As millions of American teens continue to struggle with their mental health, a new survey reveals a sizable gap between how much support teens say they get and how much support their parents think they are getting. In the.

98
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Bizarre 'garden sprinkler-like' jet is spotted shooting out of neutron star

Science Daily: Pharmacology News

A strange 'garden sprinkler-like' jet coming from a neutron star has been pictured for the first time. The S-shaped structure is created as the jet changes direction due to the wobbling of the disc of hot gas around the star -- a process called precession, which has been observed with black holes but, until now, never with neutron stars.

97
article thumbnail

How to Predict Who Will Respond to Glaucoma Treatment -- and Who Won't

Drugs.com

TUESDAY, July 16, 2024 -- An experimental blood test might be able to predict whether glaucoma patients will continue to lose their vision following treatment, researchers report.A biochemical called nicotinamide adenine dinucleotide (NAD) tends to.

article thumbnail

How astronomers are using pulsars to observe evidence of dark matter

Science Daily: Pharmacology News

Tantalizing evidence of potential dark matter objects has been detected with the help of the Universe's 'timekeepers'. These pulsars -- neutron stars which rotate and emit lighthouse-like beams of radio waves that rapidly sweep through space -- were used to identify mysterious hidden masses. Pulsars earned their nickname because they send out electromagnetic radiation at very regular intervals, ranging from milliseconds to seconds, making them extremely accurate timekeepers.

93
article thumbnail

Could Living in Poor Neighborhoods Fuel Prostate Cancer in Black Men? Study Says It Might

Drugs.com

TUESDAY, July 16, 2024 -- The stress of living in a poor neighborhood might contribute to higher rates of aggressive prostate cancer in Black men, a new study warns.Black men are more than twice as likely to die from prostate cancer than white men.

93
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Sun-like stars found orbiting hidden companions

Science Daily: Pharmacology News

Astronomers have uncovered what appear to be 21 neutron stars in orbit around stars like our Sun. The discovery is surprising because it is not clear how a star that exploded winds up next to a star like our Sun.

85
article thumbnail

Vertex sues US over limits on providing fertility services to Casgevy patients

BioPharma Drive: Drug Pricing

In the suit, Vertex argues HHS’ stance forces a “Hobson’s choice” on people with sickle cell seeking to undergo the potentially curative treatment.

article thumbnail

Scientists develop new artificial intelligence method to create material 'fingerprints'

Science Daily: Pharmacology News

Researchers have developed a new technique that pairs artificial intelligence and X-ray science.

Science 118
article thumbnail

Asceneuron raises another $100M for Alzheimer’s drug development

BioPharma Drive: Drug Pricing

The Merck KGaA spinout has a tau-regulating medicine it claims could be an “ideal therapy” for Alzheimer’s. The pitch has intrigued both healthcare investors and pharma venture arms.

article thumbnail

New analysis of Cassini data yields insights into Titan's seas

Science Daily: Pharmacology News

A new study of radar experiment data from the Cassini-Huygens mission to Saturn has yielded fresh insights related to the makeup and activity of the liquid hydrocarbon seas near the north pole of Titan, the largest of Saturn's 146 known moons.

81
article thumbnail

How Early Antibiotic Use Could Raise Kids' Asthma Risk

Drugs.com

TUESDAY, July 16, 2024 -- Early exposure to antibiotics might increase a kid’s risk of asthma by altering their gut bacteria, a new mouse study finds.Antibiotics could specifically lower gut production of indole propionic acid (IPA), a biochemical t.

article thumbnail

Nature-based solutions to disaster risk from climate change are cost effective

Science Daily: Pharmacology News

A new global assessment of scientific literature finds that nature-based solutions (NbS) are an economically effective method to mitigate risks from a range of disasters -- from floods and hurricanes to heatwaves and landslides -- which are only expected to intensify as Earth continues to warm.

81
article thumbnail

Vertex taps Orum to hunt for better ‘preconditioning’ drugs

BioPharma Drive: Drug Pricing

The deal gives Vertex rights to use Orum’s ADC-like technology to discover gentler preparatory regimens for patients receiving intensive treatments like Casgevy.

article thumbnail

Viral Vectors 101: Producing Your rAAV

addgene Blog

There are several facilities nationwide where you can obtain excellent quality, high titer rAAV ( including Addgene! ), but you can also generate rAAVs in your own lab with standard molecular biology tools and tissue culture experience. Here, we’ll go over the basics of rAAV production.

article thumbnail

Cardurion raises another $260M to fuel heart drug pipeline

BioPharma Drive: Drug Pricing

The financing, which ranks as one of the year’s larger private rounds, will help the startup advance a pair of drugs and potentially acquire other medicines.

Drugs 61
article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 52
article thumbnail

Launching a Product in Europe: Understanding Supply Chain Cost Drivers

Fierce BioTech

Launching a Product in Europe: Understanding Supply Chain Cost Drivers This paper explores the costs of setting up a supply chain in Europe for a new biopharma therapy. It outlines key cost drivers & the various levers decision makers can use to affect those costs. lbarrick Tue, 07/16/2024 - 14:15 This paper explores the costs of setting up a supply chain in Europe for a new biopharma therapy.

article thumbnail

Safe Pregnancies Possible After Stem Cell Treatment for Blood Cancer

Drugs.com

TUESDAY, July 16, 2024 -- Women who've undergone stem cell treatments for blood cancers, or for illnesses such as sickle cell disease, can successfully bring a pregnancy to term, new research shows.The German findings run counter to the perceived.

article thumbnail

PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating

Drug Channels

Last week, the Federal Trade Commission (FTC) released its interim report on pharmacy benefit managers (PBMs). The report’s unsubtle subtitle revealed how the agency views PBMs: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. ICYMI, the FTC's report relied extensively on the Drug Channels Institute's (DCI's) 2024 Economic Report on U.S.

article thumbnail

U.S. Stroke Survival Is Improving, But Race Still Plays Role

Drugs.com

TUESDAY, July 16, 2024 -- There's good news and bad for stroke survival in the United States: New research shows that Americans are now more likely to survive long-term, but that's more true for whites than for Black Americans.At least for a sample.

article thumbnail

Regulatory CMC: What to Expect During Drug Development

thought leadership

The key to successful drug development in the US is directional and focused navigation of FDA’s Investigational New Drug (IND) process. The Chemistry, Manufacturing, and Controls (CMC) section is a critical component of an IND submission and is integral to US regulatory applications.

article thumbnail

Blood Test Shows Promise in Spotting Preeclampsia Before Symptoms Surface

Drugs.com

TUESDAY, July 16, 2024 -- An experimental blood test could help detect pregnant women at increased risk for preeclampsia, a serious high blood pressure condition that can harm both mother and child.Researchers report the test looks at genetic.

52
article thumbnail

Which pharmaceutical drugs have the most patents?

Drug Patent Watch

This chart shows the pharmaceutical drugs with the greatest number of patents still in force.

article thumbnail

Long COVID Rates Are Expected to Decline: Study

Drugs.com

TUESDAY, July 16, 2024 -- People's odds for Long COVID appear to be declining with the advent of new variants of the virus, along with repeat infections and vaccinations, new research shows.That suggests that the average person's chances of.

Virus 52
article thumbnail

Expert Interpretation and Analysis of Regulatory Intelligence Are Key to FSP-Delivered Pharmacovigilance

PPD

Our recent white paper explores the many ways in which a functional service provider (FSP) engagement delivers key pharmacovigilance (PV) capabilities necessary across the product life span and across different geographical regions. Many pharma, biotech and medical device companies rely on FSP partnerships for comprehensive and cost-effective PV regulatory intelligence (RI), including: Monitoring for changes Analyzing and interpreting regulations and guidance Communicating requirements and opera